Last reviewed · How we verify
NCT05215223: WBV
Effect of Whole Body Vibration on Insulin Resistance in Females With Polycystic Ovarian Syndrome
NA trial testing whole body vibration in Polycystic Ovarian Syndrome in 46 participants. Completed in 10 October 2023.
1 October 2023
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 46 |
| Start date | 30 March 2022 |
| Primary completion | 1 October 2023 |
| Estimated completion | 10 October 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- whole body vibration
- Treadmill
Conditions studied
- Polycystic Ovarian Syndrome — all drugs for Polycystic Ovarian Syndrome →
- Insulin Resistance — all drugs for Insulin Resistance →
Sponsor
Cairo University
Who can join
Adults 20 to 35, female only, with Polycystic Ovarian Syndrome or Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the effect of whole body vibration on insulin resistance in females with polycystic ovarian syndrome
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05215223
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of whole body vibration
Trials testing the same drug.
- NCT07408570 — FREQUENCY-DEPENDENT SOLEUS REFLEX MODULATION DURING WHOLE-BODY VIBRATION · NA · enrolling by invitation
- NCT07338812 — Virtual Reality and Whole Body Vibration on Muscle Strength and Balance in Children With DMD · NA · completed
- NCT07351292 — Ultrasound or Whole Body Vibration on Knee Motion and Function in CP · NA · completed
- NCT07049718 — Effect of Whole-body Vibration Training in Patients With Renal Dialysis · NA · completed
- NCT06872697 — Impact of Whole Body Vibration on Muscle Function and Respiratory Parameters in Intensive Care Patients · NA · completed
Other recruiting trials for Polycystic Ovarian Syndrome
Currently open trials in the same condition.
- NCT06587698 — Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS · NA · recruiting
- NCT05858307 — Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05215223 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 17 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05215223.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing